Clinical Trials Browser

Immunotherapy × CNS × 1 year × Clear all

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Phase 1 Completed

21 enrolled 12 charts

Brain Neoplasms, Glioblastoma

NCT06485947 2025-07-08

DBPilot

Phase 1 Recruiting

Neuroblastoma